삼성바이오로직스

207940 코스피
1,548,000 16,000 (-1.02%)
기준 : 08/14
  • 시가총액
    716,584억
  • 주식수
    4,629만
  • PER
    38.16배
  • PBR
    9.04배
  • ROE
    23.70%
  • 결산월
    12월

26.2Q 업데이트 - 잠정실적

  • 재무분석
  • 20년 재무제표
  • 손익계산서
자세히

손익계산서를 통해 매출액과 비용 그리고 이익(손실) 규모를 알 수 있습니다. 기업의 매출액에서 모든 비용을 제외하고 남는 돈을 순이익이라고 합니다. 순이익이 많을 수록 기업가치는 높아지게 됩니다.
손익계산서를 볼 때는 '많이 팔고 많이 남기는 회사'를 찾으면 됩니다. 경쟁 기업에 비해 매출액 규모가 크고, 순이익을 많이 남기면 경쟁우위에 있는 기업이라고 할 수 있습니다.

  • 데이터
  • 연결 재무제표
  • 국제회계
설정
연환산 연간 분기
세부항목 소수점
단위 : 억원
손익계산서 2026/06 2026/03 2025/12 2025/09 2025/06 2025/03 2024/12 2024/09 2024/06 2024/03 2023/12 2023/09 2023/06 2023/03 2022/12 2022/09 2022/06 2022/03 2021/12 2021/09 2021/06 2021/03 2020/12 2020/09 2020/06 2020/03 2019/12 2019/09 2019/06 2019/03 2018/12 2018/09 2018/06 2018/03 2017/12 2017/09 2017/06 2017/03 2016/12 2016/09 2016/06 2016/03 2015/12 2015/09 2015/06 2015/03 2014/12 2014/09 2014/06 2014/03 2013/12 2013/09 2013/06 2013/03 2012/12 2012/09
매출액(수익) 55,23955,239.4 48,14548,145.4 45,56945,569.7 44,54644,546.6 39,81539,815.1
내수 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수출 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 48,14548,145.4 45,56945,569.7 44,54644,546.6 39,81539,815.1
매출원가 N/AN/A 21,59921,599.8 20,40320,403.3 19,34919,349.1 18,96418,964.9
원재료 N/AN/A 9,8219,821.7 8,9738,973.2 8,8368,836.0 8,8518,851.2
재고자산의변동 N/AN/A -2,928-2,928.9 -2,157-2,157.6 -3,028-3,028.3 -2,977-2,977.4
기타원가 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
인건비 N/AN/A 5,8205,820.0 5,5935,593.6 5,4265,426.1 5,2155,215.3
감가상각비 N/AN/A 3,3633,363.5 3,2773,277.0 3,3193,319.0 3,0673,067.2
기타 N/AN/A 5,5235,523.5 4,7174,717.0 4,7964,796.2 4,8084,808.5
매출총이익 N/AN/A 26,54526,545.5 25,16625,166.4 25,19725,197.5 20,85020,850.1
판매비와관리비 N/AN/A 4,3484,348.2 4,4744,474.1 5,0165,016.3 4,5714,571.7
급여 N/AN/A 1,4141,414.8 1,4561,456.7 1,3201,320.5 1,1771,177.3
퇴직급여 N/AN/A 105105.4 7676.0 7878.1 7070.8
복리후생비 N/AN/A 348348.6 343343.4 335335.1 284284.1
임차료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수도광열비 N/AN/A 2020.3 1919.9 1818.5 1717.8
전산처리비 N/AN/A 106106.5 119119.5 338338.4 329329.3
지급수수료 N/AN/A 909909.9 1,0251,025.3 1,2211,221.1 1,1111,111.9
용역비 N/AN/A 00.0 00.0 22.0 33.6
수출비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매수수료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매촉진비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
광고선전비 N/AN/A 7070.5 6666.1 6666.5 5555.1
애프터서비스비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
운반비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
포장비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
연구개발비 N/AN/A 368368.3 371371.8 658658.1 611611.5
개발비상각 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A -62-62.8 -8-8.1 -42-42.1 -122-122.1
감가상각비 N/AN/A 196196.5 182182.2 173173.5 209209.4
무형자산상각비 N/AN/A 142142.8 137137.9 137137.0 127127.7
기타 N/AN/A 727727.2 683683.0 709709.2 695695.0
영업이익 24,24224,242.5 22,19722,197.3 20,69220,692.2 20,18120,181.1 16,27816,278.4
EBITDA N/AN/A 28,65228,652.6 27,35427,354.0 27,29227,292.6 22,22122,221.9
금융손익 N/AN/A 781781.1 9494.1 258258.8 -572-572.9
금융수익 N/AN/A 1,9661,966.9 1,5071,507.8 1,7331,733.8 1,5541,554.7
이자수익 N/AN/A 485485.7 460460.3 432432.2 432432.0
외환거래이익 N/AN/A 1,4811,481.1 1,0471,047.4 1,2871,287.7 1,1241,124.8
외환차익 N/AN/A 1,0131,013.5 949949.0 945945.1 1,1441,144.4
외화환산이익 N/AN/A 467467.6 9898.4 342342.6 -19-19.6
기타 N/AN/A 00.0 00.0 00.0 00.0
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산평가이익 N/AN/A N/AN/A N/AN/A 55.3 77.5
파생상품이익 N/AN/A N/AN/A N/AN/A 88.5 -9-9.7
기타 N/AN/A 00.0 00.0 00.0 00.0
금융비용 N/AN/A 1,1851,185.8 1,4131,413.6 1,4741,474.9 2,1272,127.6
이자비용 N/AN/A 289289.2 291291.7 370370.2 280280.3
외환거래손실 N/AN/A 896896.5 1,1211,121.9 1,1361,136.5 1,8801,880.5
외환차손 N/AN/A 720720.2 968968.8 1,0771,077.8 1,3111,311.6
외화환산손실 N/AN/A 176176.3 153153.0 5858.7 568568.8
기타 N/AN/A 00.0 00.0 00.0 00.0
대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A N/AN/A N/AN/A -31-31.8 -33-33.3
기타 N/AN/A 00.0 00.0 00.0 00.0
기타영업외손익 N/AN/A 22.1 -30-30.9 2020.3 -8-8.0
기타영업외수익 N/AN/A 9090.2 7272.8 100100.3 6969.3
이자수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수수료수익 N/AN/A 00.0 00.0 00.0 00.0
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
임대료 N/AN/A 55.9 55.9 55.8 55.9
로열티수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자부동산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분이익 N/AN/A 33.1 88.1 88.4 99.7
무형자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손충당금환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산평가이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
채무면제이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 8181.0 5858.7 8585.9 5353.6
기타영업외비용 N/AN/A 8888.0 103103.8 8080.0 7777.4
이자비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기부금 N/AN/A 3434.1 4040.6 3636.9 3838.2
투자부동산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분손실 N/AN/A 5353.3 6262.5 3232.1 2828.2
무형자산처분손실 N/AN/A 00.0 00.0 00.0 00.0
기타자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손 N/AN/A N/AN/A N/AN/A 66.8 66.8
자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
사채상환손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 00.6 00.5 44.1 44.0
종속기업및관계기업관련손익 N/AN/A 220220.5 430430.8 180180.9 183183.7
지분법손익 N/AN/A 220220.5 430430.8 180180.9 183183.7
지분법이익 N/AN/A 271271.7 430430.8 179179.0 180180.7
지분법손실 N/AN/A -51-51.1 N/AN/A 11.8 22.9
지분법적용투자주식손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 220220.5 N/AN/A 11.8 183183.7
관계기업처분손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업관련손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
법인세비용차감전계속사업이익 N/AN/A 23,20123,201.2 21,18621,186.3 20,64120,641.2 15,88115,881.2
법인세비용 N/AN/A 5,6785,678.8 5,0435,043.0 5,1125,112.4 3,4523,452.3
중단사업이익 N/AN/A 1,2581,258.0 1,7001,700.2 430430.1 430430.1
당기순이익 19,27419,274.5 18,78018,780.4 17,84317,843.5 15,95815,958.9 12,85912,859.0
지배지분 순이익 N/AN/A 18,78018,780.4 17,84317,843.5 15,95815,958.9 12,85912,859.0
비지배지분 순이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타포괄이익 N/AN/A -27-27.9 -53-53.9 -80-80.2 -114-114.3
금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
매도가능금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업등기타포괄이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
해외사업환산손익 N/AN/A 3030.0 0-0.9 3535.2 11.4
현금흐름위험회피적립금 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
재평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타포괄이익관련법인세 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A -57-57.9 -52-52.9 -115-115.4 -115-115.8
총포괄이익 N/AN/A 18,75218,752.5 17,78917,789.5 15,87815,878.6 12,74412,744.7
지배지분 총포괄이익 N/AN/A 18,75218,752.5 17,78917,789.5 15,87815,878.6 12,74412,744.7
비지배지분 총포괄이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
주당순이익 N/AN/A 32,00132,001.2 27,14027,140.9 22,42222,422.4 18,06718,067.0
시가총액 N/AN/A 696,215696,215.9 784,631784,631.6 709,604709,604.7 706,046706,046.0
주가 N/AN/A 1,504,0001,504,000.0 1,695,0001,695,000.0 1,467,3291,467,329.0 1,459,9701,459,970.0
주가수익배수 N/AN/A 37.0737.07 43.9743.97 44.4644.46 54.9154.91
주식수(만주) N/A 4,629 4,629 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 6,696 6,696 6,696 6,696 6,696 6,696 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

20년 재무제표를 한번에! 프리미엄 서비스를 무제한으로 이용하세요. 프리미엄 55% 평생할인

밸류라인 서비스를 무제한 이용하세요 프리미엄